Role of NF-κB in TNF-α-induced COX-2 Expression in Synovial Fibroblasts from Human TMJ

Abstract

In the temporomandibular joint (TMJ) synovium, cyclo-oxygenase-2 (COX-2) expression has been believed to be directly related to joint pain and synovitis. Here we investigated the role of Nuclear Factor κB (NF-κB) in the regulation of COX-2 expression in synovial fibroblasts from human TMJ induced by tumor necrosis factor-α (TNF-α). By reverse-transcriptase/polymerase chain-reaction (RT-PCR) and Western blotting analysis, TNF-α induced a dose- and time-dependent increase in COX-2 expression. Electrophoretic mobility shift assay (EMSA) revealed that transient NF-κB activation in the COX-2 promoter was triggered by TNF-α. In parallel with transient NF-κB activation, the rapid translocation of NF-κB, particularly the p65 subunit, from the cytoplasm into the nucleus was demonstrated. Pre-treatment with pyrolidine dithiocarbamate (PDTC), one of the NF-κB inhibitors, prevented binding to the COX-2 promoter and expression of COX-2 protein in response to TNF-α. These findings indicate that activation of NF-κB is responsible for TNF-α-induced COX-2 expression in synovial fibroblasts from the TMJ.

Get full access to this article

View all access options for this article.

References

Alaaeddine N, DiBattista JA, Pelletier JP, Cloutier JM, Kiansa K, Dupuis M, et al. (1997). Osteoarthritic synovial fibroblasts possess an increased level of tumor necrosis factor-receptor 55 (TNF-R55) that mediates biological activation by TNF-alpha. J Rheumatol 24:1985–1994.

Alstergren P, Kopp S (2000). Prostaglandin E2 in temporomandibular joint synovial fluid and its relation to pain and inflammatory disorders. J Oral Maxillofac Surg 58:180–186.

Barnes PJ, Karin M (1997). Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066–1071.

Chen G, Wood EG, Wang SH, Warner TD (1999). Expression of cyclooxygenase-2 in rat vascular smooth muscle cells is unrelated to nuclear factor-kappaB activation. Life Sci 64:1231–1242.

Chin MS, Nagineni CN, Hooper LC, Detrick B, Hooks JJ (2001). Cyclooxygenase-2 gene expression and regulation in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 42:2338–2346.

Fujisawa K, Aono H, Hasunuma T, Yamamoto K, Mita S, Nishioka K (1996). Activation of transcription factor NF-kappa B in human synovial cells in response to tumor necrosis factor alpha. Arthritis Rheum 39:197–203.

Ghosh S, May MJ, Kopp EB (1998). NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16:225–260.

Inoue H, Yokoyama C, Hara S, Tone Y, Tanabe T (1995). Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin-6 expression site and cAMP response elements. J Biol Chem 270:24965–24971.

Jobin C, Morteau O, Han DS, Balfour Sartor R (1998). Specific NF-kappaB blockade selectively inhibits tumour necrosis factor-alpha-induced COX-2 but not constitutive COX-1 gene expression in HT-29 cells. Immunology 95:537–543.

10.

Kacena MA, Merrel GA, Konda SR, Wilson KM, Xi Y, Horowitz MC (2001). Inflammation and bony changes at the temporomandibular joint. Cells Tissues Organs 169:257–264.

11.

Ke J, Long X, Liu Y, Li J, Meng QG, Fang W, et al. (2005). The role of hypoxia on expression of cyclooxygenase-2 in synovial fibroblasts derived from human temporomandular joint. Zhonghua Yi Xue Za Zhi 85:1747–1751 [article in Chinese].

12.

Li W, Nishimura R, Kashishian A, Batzer AG, Kim WJ, Cooper JA, et al. (1994). A new function for a phosphotyrosine phosphatase: linking GRB2-Sos to a receptor tyrosine kinase. Mol Cell Biol 14:509–517.

13.

Lin CC, Hsiao LD, Chien CS, Lee CW, Hsieh JT, Yang CM (2004). Tumor necrosis factor-alpha-induced cyclooxygenase-2 expression in human tracheal smooth muscle cells: involvement of p42/p44 and p38 mitogen-activated protein kinases and nuclear factor-kappaB. Cell Signal 16:597–607.

14.

Marok R, Winyard PG, Coumbe A, Kus ML, Gaffney K, Blades S, et al. (1996). Activation of the transcription factor nuclear factor-kappaB in human inflamed synovial tissue. Arthritis Rheum 39:583–591.

15.

Martel-Pelletier J, Pelletier JP, Fahmi H (2003). Cyclooxygenase-2 and prostaglandins in articular tissues. Semin Arthritis Rheum 33:155–167.

16.

Myers LK, Kang AH, Postlethwaite AE, Rosloniec EF, Morham SG, Shlopov BV, et al. (2000). The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis. Arthritis Rheum 43:2687–2693.

17.

Ogura N, Tobe M, Sakamaki H, Nagura H, Abiko Y, Kondoh T (2005). Tumor necrosis factor-alpha increases chemokine gene expression and production in synovial fibroblasts from human temporomandibular joint. J Oral Pathol Med 34:357–363.

18.

Puzas JE, Landeau JM, Tallents R, Albright J, Schwarz EM, Landesberg R (2001). Degradative pathways in tissues of the temporomandibular joint. Use of in vitro and in vivo models to characterize matrix metalloproteinase and cytokine activity. Cells Tissues Organs 169:248–256.

19.

Schreck R, Meier B, Mannel DN, Droge W, Baeuerle PA (1992). Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med 175:1181–1194.

20.

Schreiber E, Matthias P, Muller MM, Schaffner W (1989). Rapid detection of octamer binding proteins with ’mini-extracts’, prepared from a small number of cells. Nucleic Acids Res 17:6419.

21.

Schroer K, Zhu Y, Saunders MA, Deng WG, Xu XM, Meyer-Kirchrath J, et al. (2002). Obligatory role of cyclic adenosine monophosphate response element in cyclooxygenase-2 promoter induction and feedback regulation by inflammatory mediators. Circulation 105:2760–2765.

22.

Seki H, Fukuda M, Iino M, Takahashi T, Yoshioka N (2004). Immunohistochemical localization of cyclooxygenase-1 and -2 in synovial tissues from patients with internal derangement or osteoarthritis of the temporomandibular joint. Int J Oral Maxillofac Surg 33:687–692.

23.

Song F, Windsor LJ (2005). Novel nonmatrix-metalloproteinase-mediated collagen degradation. Biochim Biophys Acta 1721:65–72.

24.

Takahashi T, Kondoh T, Fukuda M, Yamazaki Y, Toyosaki T, Suzuki R (1998). Proinflammatory cytokines detectable in synovial fluids from patients with temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85:135–141.

25.

Takano T, Cybulsky AV, Yang X, Aoudjit L (2001). Complement C5b-9 induces cyclooxygenase-2 gene transcription in glomerular epithelial cells. Am J Physiol Renal Physiol 281:F841–F850.

26.

Tazawa R, Xu XM, Wu KK, Wang LH (1994). Characterization of the genomic structure, chromosomal location and promoter of human prostaglandin H synthase-2 gene. Biochem Biophys Res Commun 203:190–199.

27.

Vane JR, Mitchell JA, Appleton I, Tomlinson A, Bishop-Bailey D, Croxtall J, et al. (1994). Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci USA 91:2046–2050.

28.

Yamamoto K, Arakawa T, Ueda N, Yamamoto S (1995). Transcriptional roles of nuclear factor kappaB and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J Biol Chem 270:31315–31320.

29.

Yamaza T, Masuda KF, Tsukiyama Y, Nishijima K, Murakami R, Kido MA, et al. (2003). NF-kappaB activation and iNOS expression in the synovial membrane of rat temporomandibular joints after induced synovitis. J Dent Res 82:183–188.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.44 MB